Concepedia

Publication | Open Access

Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

DOIFull Paper Access

63

Citations

27

References

2013

Year

Daniel Keizman, Maya Gottfried, Maya Ish‐Shalom, Natalie Maimon, Avivit Peer, Avivit Neumann, Hans J. Hammers, Mario A. Eisenberger, Victoria J. Sinibaldi, Henry Hayat,
The Oncologist

Abstract

Active smoking may negatively affect the PFS and OS of sunitinib-treated mRCC. Clinicians should consider advising patients to quit smoking at initiation of sunitinib treatment for mRCC.

References

YearCitations

Page 1